0001562180-22-007790.txt : 20221118
0001562180-22-007790.hdr.sgml : 20221118
20221118183123
ACCESSION NUMBER: 0001562180-22-007790
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221108
FILED AS OF DATE: 20221118
DATE AS OF CHANGE: 20221118
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Clark George C.
CENTRAL INDEX KEY: 0001878290
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41477
FILM NUMBER: 221403137
MAIL ADDRESS:
STREET 1: 215 CHURCH STREET
CITY: NEW HAVEN
STATE: CT
ZIP: 06510
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Biohaven Ltd.
CENTRAL INDEX KEY: 0001935979
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: D8
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 215 CHURCH STREET
CITY: NEW HAVEN
STATE: CT
ZIP: 06510
BUSINESS PHONE: 203-404-0410
MAIL ADDRESS:
STREET 1: 215 CHURCH STREET
CITY: NEW HAVEN
STATE: CT
ZIP: 06510
FORMER COMPANY:
FORMER CONFORMED NAME: Biohaven Research Ltd.
DATE OF NAME CHANGE: 20220629
3
1
primarydocument.xml
PRIMARY DOCUMENT
X0206
3
2022-11-08
0
0001935979
Biohaven Ltd.
BHVN
0001878290
Clark George C.
C/O BIOHAVEN PHARMACEUTICALS, INC.
215 CHURCH STREET
NEW HAVEN
CT
06510
false
true
false
false
VP, Chief Accounting Officer
Common Shares
61285.00
D
Common Shares
3000.00
I
By IRA
Stock Options (Right to buy)
7.00
2032-10-03
Common Shares
185715.00
D
The shares underlying this option became exercisable as to 50,000 of these shares on October 3, 2022, with the remainder vesting in 3 equal installments on October 3, 2023, 2024, and 2025, subject to the reporting person's continuing service as of each applicable vesting date.
/s/ George Clark
2022-11-18